IMAX’s (IMAX) “Buy” Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities reiterated their buy rating on shares of IMAX (NYSE:IMAX) in a report published on Tuesday morning,Benzinga reports. They currently have a $47.00 target price on the stock.

IMAX has been the topic of a number of other research reports. Macquarie Infrastructure boosted their price objective on shares of IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a report on Thursday, January 15th. Wedbush reissued an “outperform” rating and set a $46.00 price target on shares of IMAX in a research note on Monday. JPMorgan Chase & Co. raised IMAX from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $32.00 to $47.00 in a research note on Monday, December 15th. Wells Fargo & Company boosted their target price on IMAX from $40.00 to $47.00 and gave the stock an “overweight” rating in a research report on Thursday, December 18th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of IMAX in a report on Monday, December 29th. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $43.00.

IMAX Stock Performance

IMAX stock opened at $41.92 on Tuesday. The company has a market cap of $2.26 billion, a P/E ratio of 0.00, a price-to-earnings-growth ratio of 1.81 and a beta of 0.38. IMAX has a one year low of $20.48 and a one year high of $42.46. The business has a fifty day moving average of $36.32 and a two-hundred day moving average of $33.86.

Institutional Investors Weigh In On IMAX

Several hedge funds have recently modified their holdings of IMAX. AQR Capital Management LLC grew its holdings in shares of IMAX by 47.9% during the first quarter. AQR Capital Management LLC now owns 56,348 shares of the company’s stock worth $1,485,000 after buying an additional 18,238 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in IMAX by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,486 shares of the company’s stock worth $672,000 after acquiring an additional 1,091 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in IMAX by 7.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 159,714 shares of the company’s stock valued at $4,208,000 after acquiring an additional 11,736 shares during the last quarter. Y Intercept Hong Kong Ltd raised its holdings in IMAX by 513.3% in the 2nd quarter. Y Intercept Hong Kong Ltd now owns 47,108 shares of the company’s stock valued at $1,317,000 after acquiring an additional 39,427 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in shares of IMAX by 0.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 267,331 shares of the company’s stock worth $7,475,000 after purchasing an additional 2,343 shares during the period. 93.51% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Q4 results beat expectations — EPS of $0.58 vs. $0.43 consensus and revenue of $125.2M (up 35% Y/Y); management posted improving margins and the quarter was buoyed by strong title performance. IMAX Q4 earnings beat — MarketBeat
• Positive Sentiment: Record global box office in 2025 and bullish guidance — IMAX highlighted blockbuster tailwinds (notably the Avatar franchise) and outlined a $1.4B global box-office target for 2026, supporting revenue upside this year. Deadline: ‘Avatar’ lifts IMAX Q4
• Positive Sentiment: Analyst upward revisions — JPMorgan raised its price target to $48 with an Overweight rating and Benchmark lifted its target to $44 with a Buy, giving additional near-term upside framing for the stock. Benzinga: Analyst price target updates TickerReport: Benchmark target raise
• Positive Sentiment: Brokerage support reiterated — Rosenblatt and Wedbush reiterated buy/outperform stances, reinforcing institutional confidence after the quarter. Rosenblatt reiterates Buy
• Positive Sentiment: Content slate and alternative events are expanding — Dune 3 secured IMAX opening-weekend exclusivity in many markets, Studio Ghibli’s Kiki re-release and live F1 broadcasts add non-traditional revenue streams and calendar diversity. Beebom: Dune 3 IMAX exclusivity Collider: Studio Ghibli IMAX re-release
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for deeper detail on margin drivers and regional box-office cadence. Investors may want to review management commentary for guidance clarity. Seeking Alpha: Q4 earnings call transcript
• Negative Sentiment: Limited IMAX exposure for a major tentpole in the U.S. — reports indicate Avengers: Doomsday will not play in IMAX on its opening weekend in the U.S., which could dent short-term domestic box-office contribution from that title. Gizmodo: Avengers not in IMAX opening weekend

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.